Skip to main content
Clinical Trials/NCT02610972
NCT02610972CompletedNot Applicable

Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Case-control Study

Gynuity Health Projects2 sites in 2 countries150 target enrollmentStarted: December 1, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
150
Locations
2
Primary Endpoint
Prevalence of Urine Congophilia Using Congo Red Test GV-005

Study Overview

Brief Summary

A case-control study will evaluate the clinical utility of the Congo Red test GV-005 in following women with a clinical diagnosis of preeclampsia and clinically healthy women in the postpartum period

Detailed Description

A case-control study (n=150) will evaluate the clinical utility of the Congo Red test GV-005 in following women with a clinical diagnosis of preeclampsia and clinically healthy women in the postpartum period. Women with preeclampsia (n=100) (cases) and clinically healthy women (n=50)(controls) who are hospitalized postpartum will be recruited for the trial. All women will be asked to provide a urine sample. Samples will be collected daily during a woman's hospitalization. The Congo Red test GV-005 and a standard urine dipstick proteinuria test will be performed by a lab technician within 72 hours of sample collection. The purpose of this research is to evaluate progression of urine congophilia postpartum by following patients diagnosed with preeclampsia and clinically healthy women.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 64 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Postpartum
  • Clinical diagnosis of preeclampsia (severe, mild or superimposed) including eclampsia (n=100) OR Clinically healthy (n=50)
  • Eligible to consent for research
  • Agree to comply with study procedures
  • Able to give informed consent

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Prevalence of Urine Congophilia Using Congo Red Test GV-005

Time Frame: within 72 hours of urine sample collection

Prevalence of urine congophilia using Congo Red test GV-005

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Gynuity Health Projects
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials